top
Please input keywords
Order
*Country
日本
アメリカ
中国
オーストラリア
シンガポール
イギリス
フランス
ドイツ
スイス
イタリア
カナダ
韓国
オランダ
ベルギー
スウェーデン
その他
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hPD-L1 EL4
Common name
B-hPD-L1 EL4 Catalog number     310700
Aliases CD274, PDCD1L1 Disease  Lymphoma
Organism
Mouse
Strain  C57BL/6N
Tissue types Lymphoma Tissue  T lymphocyte

Description 

The mouse Pdl1 gene was replaced by human PD-L1 coding sequence in B-hPD-L1 EL4 cells. Human PD-L1 is highly expressed on the surface of B-hPD-L1 EL4 cells.


Application


B-hPD-L1 EL4 cells have the capability to establish tumors in vivo and can be used for efficacy studies.


Targeting strategy

Gene targeting strategy for B-hPD-L1 EL4 cells. The exogenous promoter and human PD-L1 coding sequence was inserted to replace part of murine exon 3. The insertion disrupts the endogenous murine Pdl1 gene, resulting in a non-functional transcript.

Protein expression analysis



from clipboard



PD-L1 expression analysis in B-hPD-L1 EL4 cells by flow cytometry. Single cell suspensions from wild-type EL4 and B-hPD-L1 EL4 cultures were stained with species-specific anti-PD-L1 antibody. Human PD-L1 was detected on the surface of B-hPD-L1 EL4 cells but not wild-type EL4 cells. The 6-G08 clone of B-hPD-L1 EL4 cells was used for in vivo experiments.

Tumor growth curve & Body weight changes

from clipboard



Subcutaneous homograft tumor growth of B-hPD-L1 EL4 cells. B-hPD-L1 EL4 cells (2x105) and wild-type EL4 cells (2x105) were subcutaneously implanted into C57BL/6 mice (female, 7-week-old, n=5). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hPD-L1 EL4 cells were able to establish tumors in vivo and can be used for efficacy studies.
Animals with tumor volume over 3000mm3 in the control group were euthanized.